Literature DB >> 14743158

Mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health.

Alan T Hirsch1, Peter Gloviczki, Alain Drooz, Marge Lovell, Mark A Creager.   

Abstract

BACKGROUND: There has been increasing recognition of the detrimental effect of peripheral arterial disease (PAD) on the health of Americans, and yet there is no common national program of public PAD education designed to diminish this effect. FORMAT: To heighten awareness of this problem, a 2-day PAD Public Education Strategy Meeting was recently attended by representatives of 17 professional societies and public health associations whose missions support the prevention, diagnosis, treatment, and rehabilitation of vascular diseases. This Public Education Strategy Meeting was intended to provide the rationale and structure to create a national PAD public awareness campaign to diminish the health effect of PAD and to improve cardiovascular outcomes in the United States. This document (1). provides the rationale for creation of a national PAD public education program; (2). reviews the development and success of national hypertension, hypercholesterolemia, and Women's Heart Health public education programs as models of educational efficacy; (3). elucidates how the work of many vascular professionals has led to a national consensus for creation of a national PAD public educational program; (4). provides an overview of the National Heart, Lung, and Blood Institute PAD education meeting; and (5). outlines the "next steps" required to accomplish these goals. OUTCOME: This meeting achieved consensus that we share responsibility for developing accurate, unified messages to promote PAD awareness and improved care. Participants agreed that the creation of such messages should be linked to plans to disseminate them to all Americans at risk. A consensus was reached that such messages, when commonly created and offered to the public, are most likely to achieve the rewards in better health that all Americans deserve. The Vascular Disease Foundation, a not-for-profit foundation whose mission includes public education about the prevention, diagnosis, treatment, and rehabilitation of PAD, will devote its resources to guide a new coalition in this process and to create a national PAD awareness campaign. During 2003 and 2004, the coalition will create the organizational underpinnings and time line for what will undoubtedly be a multiyear effort.
CONCLUSION: Participants of the Public Education Strategy Meeting agreed to create a broad coalition to develop a National PAD Public Awareness Program, with the objectives to develop and disseminate public education massages on PAD. A successful national PAD education program will contribute to creation of a broader mandate to improve global cardiovascular health in the United States.

Entities:  

Mesh:

Year:  2004        PMID: 14743158     DOI: 10.1016/j.jvs.2003.09.028

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

Review 1.  Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis.

Authors:  Joe F Lau; Mitchell D Weinberg; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

Review 2.  Re-evaluating the Appropriateness of Non-invasive Arterial Vascular Imaging and Diagnostic Modalities.

Authors:  Jason M Misher; Andrew M Galmer; Mitchell W Weinberg; John S Pellerito; Joe F Lau
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

3.  Peripheral arterial disease: lack of awareness in Canada.

Authors:  Marge Lovell; Kenneth Harris; Thomas Forbes; Gwen Twillman; Beth Abramson; Michael H Criqui; Paul Schroeder; Emile R Mohler; Alan T Hirsch
Journal:  Can J Cardiol       Date:  2009-01       Impact factor: 5.223

4.  Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional study.

Authors:  James J Jang; Aron I Schwarcz; Daniel A Amaez; Mark Woodward; Jeffrey W Olin; Marla J Keller; Alison D Schecter
Journal:  J Int AIDS Soc       Date:  2010-03-22       Impact factor: 5.396

5.  Suboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospital.

Authors:  Mohammed Al-Omran; Subodh Verma; Thomas F Lindsay
Journal:  Ann Saudi Med       Date:  2011 Jul-Aug       Impact factor: 1.526

6.  Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action.

Authors:  Mohammed Al-Omran
Journal:  Vasc Health Risk Manag       Date:  2012-05-28

7.  Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease.

Authors:  Mohammed Al-Omran
Journal:  Vasc Health Risk Manag       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.